Hickey Benjamin, President of RayzeBio Org., made one open market sale of Bristol Myers Squibb Co. ($BMY) shares worth $3,702 in the last 365 days, with the most recent on May 9, 2025. His total ranks 11,440th out of 11,678 insiders, well below the average $8.6 million across about 6.4 transactions per insider. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Performance Shares | 17143 | $0.00 | 17,143.0000 | 2,039,000,000 | 9999.99% | 0.00% |
| March 10, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Market Share Units | 11429 | $0.00 | 11,429.0000 | 2,039,000,000 | 9999.99% | 0.00% |
| Feb. 27, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Common Stock, $0.10 par value | 3286 | $0.00 | 18,344.0000 | 2,039,000,000 | 21.82% | 0.00% |
| Feb. 27, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Restricted Stock Units | 3286 | $0.00 | 3,286.0000 | 2,039,000,000 | 50.00% | 0.00% |
| Feb. 27, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | F | Common Stock, $0.10 par value | 1672 | $62.37 | 16,672.0000 | 2,039,000,000 | 9.11% | 0.00% |
| Feb. 1, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | F | Common Stock, $0.10 par value | 3810 | $55.05 | 15,058.0000 | 2,039,000,000 | 20.19% | 0.00% |
| Feb. 1, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Restricted Stock Units | 10079 | $0.00 | 10,079.0000 | 2,039,000,000 | 50.00% | 0.00% |
| Feb. 1, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Common Stock, $0.10 par value | 10079 | $0.00 | 18,868.0000 | 2,039,000,000 | 114.68% | 0.00% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | D | Stock Option (right to buy) | 8462 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.05% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | D | Stock Option (right to buy) | 15021 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.09% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | D | Stock Option (right to buy) | 8637 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.05% |
| June 11, 2025 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | A | Stock Option (right to buy) | 8637 | $0.00 | 8,637.0000 | 17,228,291 | 9999.99% | 0.05% |
| May 9, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | S | Common Stock, $0.10 par value | 97 | $38.01 | 8,789.0000 | 2,027,000,000 | 1.10% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Performance Shares | 20084 | $0.00 | 20,084.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Market Share Units | 13389 | $0.00 | 13,389.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | F | Common Stock, $0.10 par value | 1630 | $59.62 | 8,880.0000 | 2,027,000,000 | 15.51% | 0.00% |
| March 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Common Stock, $0.10 par value | 3286 | $0.00 | 10,510.0000 | 2,027,000,000 | 45.49% | 0.00% |
| March 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Restricted Stock Units | 3286 | $0.00 | 6,572.0000 | 2,027,000,000 | 33.33% | 0.00% |
| Feb. 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Common Stock, $0.10 par value | 10078 | $0.00 | 10,949.0000 | 2,027,000,000 | 1157.06% | 0.00% |
| Feb. 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | M | Restricted Stock Units | 10078 | $0.00 | 20,158.0000 | 2,027,000,000 | 33.33% | 0.00% |
| Feb. 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | F | Common Stock, $0.10 par value | 3725 | $58.95 | 7,224.0000 | 2,027,000,000 | 34.02% | 0.00% |
| May 30, 2024 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | A | Stock Option (right to buy) | 8462 | $0.00 | 8,462.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2024 | Mural Oncology plc | $MURA | Hickey Benjamin | Not found | A | Stock Option (right to buy) | 8462 | $3.35 | 8,462.0000 | 0 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Performance Shares | 5805 | $0.00 | 5,805.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Market Share Units | 3870 | $0.00 | 3,870.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 1, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hickey Benjamin | President, RayzeBio Org. | A | Restricted Stock Units | 9858 | $0.00 | 9,858.0000 | 2,078,000,000 | 9999.99% | 0.00% |